Press Release Archive

01.04.2010

European Commission Approves New Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension

12.30.2009

Pfizer Provides U.S. Regulatory Update On Prevnar 13™ Vaccine

12.29.2009

Pfizer Discontinues A Phase 3 Trial Of Figitumumab In Non-Small Cell Lung Cancer (NSCLC) For Futility

12.23.2009

Pfizer’s Lyrica Receives Complete Response Letter From FDA For Generalized Anxiety Disorder Monotherapy Treatment

12.22.2009

Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

12.18.2009

Despite Stresses of Today, Survey Finds Women and Men Set Health and Wellness Goals – But Sex Often Influences Success

12.17.2009

FDA Approves SPIRIVA® HandiHaler® for the Reduction of COPD Exacerbations

12.16.2009

Toviaz 8 Mg Was More Effective Than Detrol LA In Treating Urge Urinary Incontinence In Patients With Overactive Bladder

12.14.2009

Takeda and Pfizer to Co-Promote Takeda’s Actos® (Pioglitazone HCl) for the Treatment of Type 2 Diabetes in China

12.14.2009

Pfizer Declares an 18-Cent First-Quarter 2010 Dividend

12.14.2009

New pH1N1 Vaccine Available for Swine

12.12.2009

Pfizer Inc. Affirms Confidence In Its Hormone Therapy Medicines As Important Treatment Options

12.12.2009

Pfizer Announces Neratinib Data In HER2 Positive Breast Cancer

12.10.2009

Prevenar 13 to provide the broadest coverage of any pneumococcal conjugate vaccine for infants and young children

12.10.2009

Adele Gulfo joins Pfizer as U.S. President, Primary Care

12.10.2009

Pfizer Extends Commitment to Help Unemployed Americans

12.09.2009

Pfizer Announces Updated Trial Results for AROMASIN® (exemestane tablets) In Switch And Upfront Settings

12.08.2009

Physicians More Likely To Report Drug Safety Information Through Electronic Health Records System

12.08.2009

CORRECTING and REPLACING Pfizer And Crown Bioscience Announce A Collaboration To Research And Develop New Treatments For Asian Cancers

12.03.2009

Pfizer To Present Clinical Data From Expanded Breast Cancer Portfolio At The San Antonio Breast Cancer Symposium

11.30.2009

Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher’s Disease Treatment

11.19.2009

Pfizer Receives FDA Approval For Geodon® (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults

11.19.2009

FDA Approves Intravenous Formulation Of Pfizer’s Revatio® (Sildenafil) For The Treatment Of Pulmonary Arterial Hypertension

11.19.2009

FDA Advisory Committee Finds Data Support the Claim That SPIRIVA® HandiHaler® Reduces COPD Exacerbations

11.18.2009

Pfizer Encourages Families To Bring Their Dogs To This Year’s Holiday Celebration

11.18.2009

FDA Advisory Committee Finds Data Support the Safety and Effectiveness of Prevnar 13™ Vaccine for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children

11.17.2009

Pfizer and DNDi Advancing International Research Efforts In The Fight Against Neglected Tropical Diseases

11.17.2009

Pfizer Submits New Pediatric Data For Lipitor® (Atorvastatin) To The European Medicines Agency (EMEA)

11.08.2009

Pfizer Announces Global Research Network

11.04.2009

Significantly More Smokers With Mild-To-Moderate COPD Quit Smoking Using CHANTIX/CHAMPIX® (Varenicline) Compared With Placebo

11.02.2009

Pfizer And Medivation Initiate Two Phase 3 Trials Of Dimebon In Patients With Moderate-To-Severe Alzheimer’s Disease

10.29.2009

Pfizer Completes Consent Solicitation

10.29.2009

Pfizer’s Board Of Directors Approves Shareholder Advisory Vote On Executive Compensation

10.22.2009

Pfizer Declares a 16-Cent Fourth-Quarter 2009 Dividend

10.19.2009

Pfizer Reports Third-Quarter 2009 Results

10.19.2009

New Pfizer Animal Health is Unveiled with Acquisition of Wyeth

10.17.2009

CP-690,550, Pfizer’s Oral JAK Inhibitor, Demonstrates Response Both Alone And In Combination With Methotrexate At 24 Weeks In Patients With Active Rheumatoid Arthritis

10.15.2009

Pfizer Commences Consent Solicitation for Amendments to Wyeth Indenture

10.15.2009

Pfizer And Wyeth Become One: Working Together For A Healthier World™

10.14.2009

Pfizer Completes Acquisition Of Wyeth

10.13.2009

Pfizer Receives Clearance From The U.S. Federal Trade Commission And The Canadian Competition Bureau For Wyeth Acquisition

10.13.2009

Pfizer Announces Settlement And License Agreement With Mylan Related To Vfend®

10.08.2009

FDA Advisory Committee Recommends Approval of Pfizer’s Selzentry for Use in Patients Starting HIV Therapy for the First Time

09.29.2009

Pfizer Receives Approval From Australian Competition And Consumer Commission (ACCC) For Pending Acquisition Of Wyeth

09.28.2009

Pfizer Receives Approval from China’s Ministry of Commerce for Pending Wyeth Acquisition

09.28.2009

Frances D. Fergusson And John P. Mascotte Elected To Pfizer’s Board Of Directors

09.24.2009

Pfizer and Eisai Continue Aricept Collaboration

09.23.2009

Pfizer Launches Phase 3 Clinical Trial With Novel Alk Inhibitor In Non-Small Cell Lung Cancer Patients With Specific Gene Mutation